logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Immunotherapy Of Cancer Cancer Drug Discovery And Development 1st Edition Mary L Disis

  • SKU: BELL-2091242
Immunotherapy Of Cancer Cancer Drug Discovery And Development 1st Edition Mary L Disis
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Immunotherapy Of Cancer Cancer Drug Discovery And Development 1st Edition Mary L Disis instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 4.28 MB
Pages: 517
Author: Mary L. Disis
ISBN: 1588295648
Language: English
Year: 2005
Edition: 1

Product desciption

Immunotherapy Of Cancer Cancer Drug Discovery And Development 1st Edition Mary L Disis by Mary L. Disis 1588295648 instant download after payment.

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.

Related Products